Physician profile
Sithara Thalluri
NPI 1437903473
$1,922.63
in general payments reported to CMS, 2019-2025
13 companies · $1,923 in 2025
The $1,923 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Travel and Lodging: $67.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.74 |
| Travel and Lodging | $67.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $439.86 | 2025 | Penumbra System, Indigo System |
| Stryker Corporation | $401.82 | 2025 | Artix Mt, Flowtriever |
| Integra Lifesciences Corporation | $323.46 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tactile Systems Technology INC | $204.21 | 2025 | Flexitouch Plus, Nimbl |
| Boston Scientific Corporation | $171.17 | 2025 | Eluvia |
| Kerecis Limited | $92.27 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Shockwave Medical, INC | $79.52 | 2025 | |
| Medtronic, INC. | $61.29 | 2025 | Valiant Captivia |
| Abbott Laboratories | $55.90 | 2025 | Esprit |
| W. L. Gore & Associates, INC. | $28.62 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $24.29 | 2025 | |
| Solventum Corporation | $21.43 | 2025 | Prevena, 3m Cavilon, V.A.C. Veraflo |
| Smith+Nephew, INC. | $18.79 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sithara Thalluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.